Saturday 17 October 2026
Export YI’s income statement to Excel — free account
111, Inc. Sponsored ADR
YI Healthcare Medical Distribution
111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.
3.09
0.00
0.00%
Follow YI
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 3 | 5 | 3 | 4 | 3 | 7 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 0.36 | 0.61 | 1.69 | 2.23 | 2.36 | 2.82 | 3.36 | 3.31 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.10 | 0.05 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 2.75 |
Altman Z″-Score (non-manufacturers) |
4.47 | (2.55) | 4.38 | (2.02) | (0.71) | (3.14) | (3.08) | (4.56) | (4.01) | (5.61) |
P/Operating CF |
0.00 | 0.00 | (1.65) | (4.62) | (2.42) | (0.58) | 2.89 | (0.48) | (0.64) | 4.95 |
Beneish M-Score |
— | (4.06) | (1.81) | 0.12 | (1.89) | (0.90) | (3.17) | (2.35) | (3.12) | (3.28) |
P/B ratio |
0.00 | 0.00 | 0.14 | 0.50 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.14 | 0.50 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | (0.06) | (0.12) | (0.04) | (0.04) | (0.02) | (0.02) | (0.02) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.44 | 2.15 | 0.78 | 1.53 | 0.68 | 0.00 | 112.75 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.43 | 8.70 | 0.72 | 24.56 | 0.53 | (1.21) | (2.25) |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.43 | 5.86 | 0.62 | 3.30 | 0.40 | (2.43) | (4.73) |
Quick Ratio |
4.28 | 2.39 | 3.61 | 0.99 | 1.09 | 0.63 | 0.52 | 0.44 | 0.40 | 0.45 |
Current Ratio |
5.23 | 3.63 | 4.79 | 1.92 | 1.76 | 1.32 | 1.19 | 1.07 | 1.13 | 1.09 |
Net Debt/EBITDA |
1.74 | 1.93 | 2.84 | 1.25 | 3.03 | 1.11 | 2.25 | 1.02 | (18.74) | (44.78) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 5.90% | 7.57% | 8.25% | 5.15% | 10.94% | 5.77% | 8.53% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.12 | 0.56 | (1.71) | (0.44) | (0.57) | (0.24) | (0.26) |
Asset Turnover |
0.77 | 0.97 | 1.53 | 2.49 | 3.62 | 4.07 | 3.93 | 4.49 | 4.83 | 5.16 |
Operating CF/Net income |
0.93 | 0.82 | 0.90 | 1.03 | 0.26 | 1.03 | 0.06 | 1.14 | (4.06) | (1.79) |
Capex/Depreciation |
0.00 | (0.46) | (1.31) | (2.09) | (1.83) | (2.29) | (0.75) | (0.38) | (0.87) | (0.37) |
Interest Coverage |
— | (4,798.62) | (58.23) | (136.32) | (53.69) | (117.03) | (27.60) | (17.38) | 0.07 | (0.07) |
| 51.65% | 31.08% | (313.93%) | (49.64%) | (80.68%) | (547.31%) | 145.42% | 77.35% | 10.20% | 9.82% | |
| (36.72%) | (25.19%) | (32.49%) | (31.46%) | (20.13%) | (21.96%) | (12.12%) | (11.78%) | (2.17%) | (2.73%) | |
ROIC |
0.00% | 0.00% | (213.47%) | (180.08%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(58.13%) | (45.50%) | (31.34%) | (67.71%) | (35.49%) | (89.07%) | (74.55%) | (176.42%) | (19.04%) | (34.53%) |
Average Days of Receivables |
38.23 | 7.76 | 5.84 | 6.03 | 7.26 | 11.88 | 13.20 | 13.11 | 10.47 | 7.55 |
Research and Development Expense of Revenue |
6.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
43.94% | 25.38% | 20.09% | 11.74% | 6.43% | 5.80% | 4.91% | 4.50% | 2.67% | 2.61% |
Intangible Assets out of Total Assets |
0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 1.03% | 2.88% | 1.37% | 0.92% | 1.17% | 1.20% | 1.52% | 0.14% | 0.08% |
Graham Net Nets |
0.00 | 0.00 | 6.84 | 1.68 | 0.68 | (2.68) | (3.69) | (7.60) | (20.48) | (5.12) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.79 | 34.41 | 38.41 | 12.29 | 16.33 |
Earnings Yield |
(4.35%) | (4.35%) | (6.51%) | (133.73%) | (117.99%) | (365.71%) | (242.62%) | (400.00%) | (103.23%) | (39.06%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | (133.63%) | (46.40%) | (434.90%) | (98.40%) | (596.26%) | 336.96% | 36.37% |
Revenue per Share |
1.61 | 40.28 | 52.24 | 69.37 | 152.58 | 235.11 | 235.21 | 249.74 | 229.63 | 206.35 |
Operating CF per Share |
(0.71) | (8.58) | (10.03) | (8.99) | (2.17) | (13.03) | (0.40) | (7.47) | 4.19 | 1.96 |
Capex per Share |
0.00 | (0.29) | (0.43) | (0.43) | (0.48) | (1.18) | (0.53) | (0.14) | (0.23) | (0.07) |
Free Cash Flow per Share |
(0.71) | (8.86) | (10.46) | (9.42) | (2.65) | (14.21) | (0.93) | (7.61) | 3.96 | 1.89 |
Cash per Share |
1.12 | 19.36 | 32.37 | 12.25 | 30.11 | 17.85 | 16.06 | 11.26 | 8.26 | 10.05 |
Shareholders Equity per Share |
1.92 | (39.66) | 35.79 | 13.58 | 7.56 | (2.88) | (7.11) | (9.94) | (10.49) | (11.86) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.92 | (39.66) | 35.79 | 13.58 | 7.56 | (2.88) | (7.11) | (9.94) | (10.49) | (11.86) |
Free Cash Flow |
(58.50) | (31.91) | (52.03) | (77.11) | (21.83) | (117.88) | (7.78) | (64.14) | 34.01 | 16.41 |
Working Capital |
104.85 | 79.99 | 173.45 | 101.70 | 190.50 | 105.41 | 74.05 | 26.52 | 42.07 | 24.48 |
Capital Expenditures |
(1.04) | (1.03) | (2.14) | (3.51) | (3.93) | (9.79) | (4.42) | (1.15) | (2.02) | (0.62) |
Net Current Asset Value |
104.85 | (147.74) | 172.27 | 92.66 | 38.72 | (77.87) | (93.76) | (105.70) | (109.08) | (113.95) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.44 | 2.15 | 0.78 | 1.53 | 0.68 | 0.00 | 112.72 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.43 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 0.87 | 0.56 | 0.39 | 0.32 | 0.34 | 0.84 | 0.63 | 0.52 | 0.56 |
Cash ROIC |
(23.40%) | 43.68% | (15.35%) | (34.26%) | (6.32%) | (71.49%) | (7.74%) | (109.20%) | 1,173.30% | 148.15% |
Accounts Receivable Turnover |
9.27 | 17.15 | 71.78 | 83.93 | 73.16 | 44.08 | 29.17 | 28.74 | 29.85 | 38.31 |
Accounts Payable Turnover |
7.11 | 7.85 | 9.74 | 11.49 | 10.52 | 9.86 | 7.87 | 8.28 | 8.09 | 8.07 |
Inventory Turnover |
5.55 | 6.21 | 9.33 | 10.82 | 12.82 | 12.63 | 9.35 | 9.52 | 9.54 | 10.17 |
Average Days of Payables |
42.89 | 53.84 | 46.07 | 42.83 | 49.99 | 41.66 | 50.82 | 41.13 | 46.30 | 39.56 |
Days of Inventory on Hand |
62.39 | 60.53 | 45.76 | 46.87 | 35.70 | 34.66 | 43.16 | 36.75 | 37.31 | 30.80 |
Average Receivables |
14.24 | 8.45 | 3.62 | 6.76 | 17.18 | 44.23 | 67.18 | 73.25 | 66.10 | 46.87 |
Average Payables |
16.89 | 16.73 | 25.12 | 47.35 | 114.16 | 187.96 | 233.65 | 239.82 | 229.80 | 209.61 |
Average Inventory |
21.64 | 21.14 | 26.22 | 50.26 | 93.66 | 146.70 | 196.62 | 208.62 | 195.00 | 166.43 |
Average Assets |
171.57 | 149.14 | 170.14 | 228.11 | 347.57 | 478.74 | 498.65 | 469.37 | 408.50 | 348.28 |
Average Common Equity |
(121.97) | (120.88) | 17.61 | 144.58 | 86.73 | 19.20 | (41.56) | (71.51) | (86.96) | (96.67) |
Columns are period end dates